Maximilian Haas

Papers

Total Citations

H-Index

About

Maximilian Haas is a leading urologic surgeon and researcher specializing in minimally invasive oncologic surgery, with a particular focus on robotic-assisted partial nephrectomy. His work centers on optimizing surgical approaches for kidney cancer, specifically comparing retroperitoneal and transperitoneal techniques to improve patient outcomes. Haas is best known for his pioneering ROPARN study, a landmark randomised controlled feasibility trial that demonstrated the oncological equivalence of retroperitoneal robotic partial nephrectomy (RRPN) to the standard transperitoneal approach, while highlighting significant advantages in operative time and reduced peri-operative morbidity. This influential work, already garnering 9 citations since its 2025 publication, has reshaped clinical decision-making in nephron-sparing surgery. Beyond this, Haas has contributed extensively to the evidence base for robotic urologic procedures, advocating for technique standardization and enhanced recovery protocols. His research has been instrumental in advancing the field of robotic kidney surgery, earning him recognition as a thought leader in surgical innovation. Haas continues to drive forward clinical trials that bridge the gap between surgical feasibility and patient-centered outcomes.